Download Files:
For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.
Products Details
Product Description
– PAK4-IN-5 (Compound 12i) is a potent inhibitor of PAK4 (IC50: PAK4 at 7.68 nM, PAK1 at 1872.01 nM) that forms stable interactions with the PAK4 enzyme. This compound effectively inhibits the proliferation and migration potential of MDA-MB-231 cells by hindering the phosphorylation of PAK4 and LIMK1. Additionally, PAK4-IN-5 arrests the cell cycle in the G0/G1 phase, induces apoptosis, and prompts the production of reactive oxygen species. The LD50 in mice is greater than 500 mg/kg (oral).
For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.
Web ID
– T201422
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C31H28ClN5O
Molecular Weight
– C31H28ClN5O
SMILES
– O=C(NC1=CC=CC(Cl)=C1)C(C=C2)=CC=C2C(N3)=NC(C3=C4)=CC=C4C5=CC=C(N6CCN(C)CC6)C=C5
Target
– Others
Pathway
– Metabolism|||Apoptosis|||NF-κB|||Cytoskeletal Signaling|||Immunology/Inflammation
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
Sodium Nitroprusside
64 CAD – 139 CADPrice range: 64 CAD through 139 CAD
1000 in stock
Proudly representing
150+ years of combined research-supply heritage

